Dr Mole has extensive experience with the design, development, manufacture and regulatory approval of biotechnology products in a number of territories, including SE Asia, having previously taken four products from the research bench to the market. Initially his interest was in the medical sector, but since 2007 has focused on animal health applications and has worked in a variety of roles with Moredun Research Institute, Roslin Foundation and the Institute for Animal Health. During this time he established Inocul8, a company focused on the development of novel veterinary vaccines, which assisted creating Wormvax Australia and the first commercially available vaccine (Barbervax) against nematodes infections in livestock.

Dr Mole is currently Commercialisation Manager within the Moredun Group and Fund Manager for the Genomia Seed Fund.